Oncotarget: A novel format for recombinant antibody-interleukin-2 fusion proteins

Oncotarget recently published a novel format for recombinant antibody-interleukin-2 fusion proteins exhibits superior tumor-targeting properties in vivo which reported that here, the authors describe four novel formats for the L19-IL2 fusion

Read more